Parallel Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,835
| Closed | -$521K | – | 3367 |
|
|
2021
Q2 | $521K | Buy |
2,835
+296
| +12% | +$54.4K | 0.02% | 375 |
|
|
2021
Q1 | $388K | Buy |
2,539
+96
| +4% | +$14.7K | 0.02% | 423 |
|
|
2020
Q4 | $382K | Sell |
2,443
-203
| -8% | -$31.7K | 0.02% | 382 |
|
|
2020
Q3 | $303K | Sell |
2,646
-396
| -13% | -$45.3K | 0.02% | 420 |
|
|
2020
Q2 | $341K | Sell |
3,042
-1,766
| -37% | -$198K | 0.02% | 383 |
|
|
2020
Q1 | $431K | Buy |
4,808
+1,265
| +36% | +$113K | 0.03% | 278 |
|
|
2019
Q4 | $383K | Buy |
3,543
+847
| +31% | +$91.6K | 0.03% | 340 |
|
|
2019
Q3 | $264K | Buy |
2,696
+50
| +2% | +$4.9K | 0.02% | 395 |
|
|
2019
Q2 | $347K | Sell |
2,646
-229
| -8% | -$30K | 0.03% | 312 |
|
|
2019
Q1 | $389K | Buy |
2,875
+162
| +6% | +$21.9K | 0.04% | 260 |
|
|
2018
Q4 | $264K | Buy |
2,713
+1,929
| +246% | +$188K | 0.04% | 305 |
|
|
2018
Q3 | $109K | Buy |
784
+53
| +7% | +$7.37K | 0.01% | 578 |
|
|
2018
Q2 | $90K | Buy |
731
+437
| +149% | +$53.8K | 0.01% | 569 |
|
|
2018
Q1 | $33K | Buy |
294
+58
| +25% | +$6.51K | 0.01% | 841 |
|
|
2017
Q4 | $28K | Sell |
236
-192
| -45% | -$22.8K | ﹤0.01% | 896 |
|
|
2017
Q3 | $49K | Sell |
428
-97
| -18% | -$11.1K | 0.01% | 689 |
|
|
2017
Q2 | $72K | Sell |
525
-130
| -20% | -$17.8K | 0.01% | 584 |
|
|
2017
Q1 | $85K | Buy |
655
+320
| +96% | +$41.5K | 0.02% | 497 |
|
|
2016
Q4 | $41K | Buy |
+335
| New | +$41K | 0.01% | 654 |
|